Evergreen Life has made a strategic acquisition to continue its drive to improve clinical pathways and patient outcomes.
The business has brought in Cievert to its portfolio, with the two working across primary and secondary care to integrate products and leverage Evergreen’s expertise across healthcare.
Vaccess, a bespoke vaccination management system, is the latest product that has seen the benefits of the partnership with clinical system integration for the primary and secondary care vaccine solution becoming available in time for flu season.
Built to be both patient facing and clinician centric, the platform automates vaccine eligibility checks for influenza as well as COVID-19 boosters, and allows patients to book, cancel, or reschedule their own vaccination appointment at a time and location that suits them and clinic staff. The solution helps to streamline the end-to-end vaccination process and significantly reduces demand on GP phone lines during the busy winter period.
Established in 2014 in Manchester by former clinical pharmacist Stephen Critchlow, Evergreen Life’s aim is to put people in control of their health and wellbeing to get the care they want. The Evergreen Life app provides a quick and easy way for people to manage their patient services – such as booking a doctor’s appointment and ordering a repeat prescription with the option of free home delivery.
Established in 2011 by former NHS radiographer, Chris Kennelly, Cievert is a digital health company specialising in software that improves the efficiency of complex clinical pathways in NHS hospitals across the UK. Their first software application improved the quality of cancer pathways which resulted in reduced waiting times for treatments, as well as reducing admin for staff.
With offices in Newcastle, Manchester and London, Cievert is perfectly placed to service the entirety of the UK. Cievert’s software can now be found in NHS cancer centres across the country.
“We believe that people should be empowered to get the wellbeing and health that they want and be supported to get the care that they need,” says Mark Hindle, COO of Evergreen Life.
“Cievert has a track record of using technology to help the NHS to improve access to care; managing referrals for cancer and other specialist treatments, managing thousands of vaccination bookings for sites across the UK and helping patients to be followed up remotely in the community with patient reported outcomes and assessments. By working together in this way, we can join up more parts of the health and care system around the person as part of our mission to deliver people powered health.
“Refreshingly, Chris and the team at Cievert have always focussed on patients as people and we have a shared ethos around connecting health and wellbeing data so that it both benefits the individual, the NHS, and the wider community.”
Chris Kennelly, CEO of Cievert, adds: “We realised that Cievert and Evergreen Life shared a range of research interests, and we could deliver greater services to our customers, and ultimately patients, by being a single organisation.
“Our mission is to make routine healthcare a thing of the past, and by integrating with Evergreen technology we will be able to share clinical data between the patient, secondary care and primary care, meaning we can start to support interesting activity like supported self-care, improve clinical risk stratification, remote monitoring and population health.”
